Yasser's having a sissy fit, the con mans in a tizzy….
“In a clinical study, 28% of patients on Juxtapid had diarrhea, nausea, vomiting, and abdominal pain. However, those side effects are minimal compared to those caused by traditional statin treatments. Liver tests are also required for patients before and after treatments, since Juxtapid can cause liver problems, according to the FDA. Therefore, patients considering using Juxtapid are required to first enroll in a Juxtapid REMS (Risk Evaluation and Mitigation Strategy) program for liver testing.
A very high-priced treatment
Investors are waiting to see if Juxtapid can break out of its niche and become a mainstream high LDL treatment, but that kind of approval could be years away. For now, Aegerion can only treat its small group of patients suffering from homozygous familial hypercholesterolemia, which only affects one in a million people. Due to the rarity of the disease, a year’s supply of Juxtapid costs $295,000 -- recently increased from $235,000.”